Additive manufacturing using low viscosity biomaterials UKIPO Grant
Copner Biotech is pleased to announce the granting of its second patent, GB2609532, a method for 3D printing low viscosity bioINK's. GB2609532, protects the novel way in which we are able to print low viscosity biomaterials to resolutions suitable for vascular tissue engineering. Copner Biotech’s continuous Research and Development programs have resulted in numerous other patent filings which will be granted in due course, to protect our suite of innovative products and services. In the spirit of openness and cooperation, these patents (and in the future related patents including US and European counterparts) are available for licence on mutually agreeable terms, with the necessary technical support to help your business make full use of those rights.